checkAd
    Startseite > Aktien > PainReform > Nachrichten
    PainReform Aktie
    0,7705
     
    USD
    -7,81 %
    -0,0653 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,7700
     
    USD
    100 STK
    Geldkurs 20.05.24
    0,8100
     
    USD
    3.900 STK
    Briefkurs 20.05.24
    ISIN: IL0011651580 · WKN: A2QB4E · SYM: PRFX · Israel

    Neueste Nachrichten

    PainReform Provides Business Update for the First Quarter of 2024
    15.05.24 · globenewswire · PainReform
    PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
    08.05.24 · globenewswire · PainReform
    PainReform Announces Closing of $4 Million Public Offering
    18.04.24 · globenewswire · PainReform
    PainReform Announces Pricing of $4 Million Public Offering
    16.04.24 · globenewswire · PainReform
    PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
    09.04.24 · globenewswire · PainReform
    PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
    02.04.24 · globenewswire · PainReform
    PainReform Provides Year-End Business Update
    01.03.24 · globenewswire · PainReform
    PainReform to Present at the Microcap Conference in Atlantic City
    22.01.24 · globenewswire · PainReform
    PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
    03.01.24 · globenewswire · PainReform
    PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
    27.12.23 · globenewswire · PainReform
    PainReform Provides Business Update for the Third Quarter of 2023
    15.11.23 · globenewswire · PainReform
    PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File
    11.09.23 · globenewswire · PainReform